Our results highlight a novel mechanism for exploring how Notch3 regulates EMT as well as the crosstalk between Notch and Wnt signaling pathways; this may have important implications for identifying new biomarkers for the prognosis of and as therapeutic targets in breast cancer. This evidence concerns the gene NOTCH3 and breast carcinoma.